Exploration Capital, LLC's Form 4 filing
Fresh Tracks Therapeutics, Inc. (FRTX) · filed Mar 13, 2024
- Accession no.
- 0001213900-24-022246
- Filed
- Mar 13, 2024
- Trade date
- Mar 11-13, 2024
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 3 non-derivative transactions. Open-market purchases total $15.0K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Exploration Capital, LLCCIK 0002003514 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 11, 2024 | Common Stock | PPurchaseAcquired | +5,703 | $0.91 | +$5,189.73 | 953,216 | Direct | |
| Mar 12, 2024 | Common Stock | PPurchaseAcquired | +1,500 | $0.91 | +$1,365 | 954,716 | Direct | |
| Mar 13, 2024 | Common Stock | PPurchaseAcquired | +9,126 | $0.92 | +$8,395.92 | 963,842 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.